<DOC>
	<DOCNO>NCT01449513</DOCNO>
	<brief_summary>This trial conduct explore biological effect skin follow treatment PEP005 Gel , 0.05 % administer two consecutive day , assess reflectance confocal microscopy .</brief_summary>
	<brief_title>PEP005 Gel - Biological Effects Actinic Keratosis Assessed Reflectance Confocal Microscopy</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<criteria>1 . Male female subject least 18 year age 2 . Subjects AK lesion subclinical AK lesion within contiguous 25 cm2 area upper extremity 3 . Subjects must 25 cm2 area normal skin inner upper arm 4 . Female subject must either : • Nonchildbearing potential , postmenopausal , confirm clinical history sterility • Childbearing potential , confirm negative urine pregnancy test prior exposure . 5 . Female subject childbearing potential must willing consent use high effective method contraception 6 . Ability follow trial instruction likely complete trial requirement 7 . Obtained write informed consent prior trialrelated procedure 1 . Location select treatment area : • Within 5 cm incompletely heal wound infected area skin • Within 10 cm suspect basal cell carcinoma ( BCC ) squamous cell carcinoma ( SCC ) 2 . History evidence skin condition trial indication would interfere evaluation investigational product 3 . Clinical diagnosis/history evidence medical condition would expose subject undue risk significant AE interfere assessment safety course trial , determine Investigator clinical judgment 4 . Anticipated need inpatient hospitalisation inpatient surgery trial period . 5 . Current participation interventional clinical trial 6 . Subjects receive treatment nonmarketed drug product within last two month 7 . Previous enrolment clinical trial 8 . Prohibited Therapies and/or Medications 2 week prior Screening visit within 2 cm select treatment area : •Cosmetic therapeutic procedure •Use acidcontaining therapeutic product • Use topical salve topical steroid 9 . Prohibited Therapies and/or Medications : within 4 week prior Screening visit : • Treatment immunomodulators , cytotoxic drug interferon/interferon inducer , systemic medication suppress immune system , UVB 10 . Prohibited Therapies and/or Medications : within 8 week prior Screening visit : • Treatment 5FU , imiquimod , diclofenac , photodynamic therapy : within 2 cm select treatment area . 11 . Use systemic retinoids</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>